Rituximab and FAB/LMB 96 Chemotherapy in Children With Stage III/IV B-Cell Non-Hodgkin Lymphoma: A Children’s Oncology Group Report

Leukemia - United Kingdom
doi 10.1038/leu.2012.255

Related search